For 35 years, Arm Holdings sold blueprints, not chips. Apple, Qualcomm, Nvidia and Amazon paid Arm to license its processor designs, then made the silicon themselves. On May 6, 2026, Arm formalized a different future: a $15 billion direct chip-sales business by fiscal 2031, anchored by an in-house data center processor called the Arm AGI CPU. Customer demand for the chip has already doubled to more than $2 billion for fiscal years 2027–2028 since the March 24 launch, and an IBM collaboration announced in April extended the AGI CPU's reach toward enterprise mainframes.
The record Q4 results — $1.49 billion in quarterly revenue, up 20% year-over-year — were complicated on the earnings call by a supply-chain admission: Arm has locked in manufacturing capacity for the first $1 billion of AGI CPU orders but is still working to secure supply for the rest. That caveat sent the stock on a sharp after-hours swing — up 13% on the print, then down 6% once investors absorbed the supply gap and CEO Rene Haas's disclosure that smartphone unit growth turned negative. First production shipments remain on track for the fourth quarter of fiscal 2027 (early calendar 2027), but how quickly Arm resolves the supply constraint will determine whether the $15 billion target stays on schedule.